Saskatchewan provides coverage for the three available SMA treatments through their Exception Drug Status (EDS) Program.
SMA Treatments:
Evrysdi – Risdiplam
Spinraza – Nusinersen
Zolgensma – onasemnogene abeparvovec
The coverage details are not publicly shared but they can be obtained by contacting the Drug Program at 1-800-667-7581 for more information. Please discuss your eligibility with your health-care provider.
Click here for more information and search for each of the above treatments within the document.